Scinai Immunotherapeutics Ltd.

Nasdaq:SCNI

Biological Products, (No Diagnostic Substances)·JERUSALEM, L3

Financials

2 shown

Type	Period	Ended	Filed
10-Q	Q1 2023	3/31/23	5/15/23	→
10-K	FY 2022	12/31/22	4/17/23	→

News (8-K)

4 shown

Filed	Type	Description
6/8/23	Agreement	Entry into a Material Definitive Agreement	→
5/11/23	Exec Change	Departure or Appointment of Directors or Certain Officers	→
5/4/23	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
5/4/23	Reg FD	Regulation FD Disclosure	→

Prospectuses & Registrations

40 shown

Filed	Form	Description
11/12/25	S-8	REGISTRATION STATEMENT	→
10/6/25	424B3	424B3	→
9/22/25	F-1	REGISTRATION STATEMENT	→
6/5/25	424B3	PROSPECTUS SUPPLEMENT	→
3/13/25	424B3	424B3	→
3/11/25	F-1/A	AMENDMENT NO. 1 TO FORM F-1	→
↓

Filing History(456 filings)

TypeDateAccessionPeriodSize

6-K

Feb 25, 2026

0001213900-26-020179REPORT OF FOREIGN PRIVATE ISSUER

Feb 25, 2026

70.5 KB

SCHEDULE 13G/A

Feb 17, 2026

0001948744-26-000001

—

8.8 KB

6-K

Feb 17, 2026

0001213900-26-016935REPORT OF FOREIGN PRIVATE ISSUER

Feb 17, 2026

141.7 KB

6-K

Dec 23, 2025

0001213900-25-125287REPORT OF FOREIGN PRIVATE ISSUER

Dec 23, 2025

30.9 KB

6-K

Dec 2, 2025

0001213900-25-117042REPORT OF FOREIGN PRIVATE ISSUER

Dec 2, 2025

64.6 KB

6-K

Nov 13, 2025

0001213900-25-110087REPORT OF FOREIGN PRIVATE ISSUER

Nov 13, 2025

963.1 KB

6-K

Nov 13, 2025

0001213900-25-110052REPORT OF FOREIGN PRIVATE ISSUER

Nov 13, 2025

171.3 KB

S-8

Nov 12, 2025

0001213900-25-109050REGISTRATION STATEMENT

—

295.8 KB

6-K

Oct 6, 2025

0001213900-25-096290REPORT OF FOREIGN PRIVATE ISSUER

Oct 6, 2025

27.5 KB

424B3

Oct 6, 2025

0001213900-25-096284PROSPECTUS

—

347.6 KB

SCHEDULE 13G/A

Oct 1, 2025

0000912282-25-001013

—

11.7 KB

EFFECT

Sep 30, 2025

9999999995-25-003244

—

1.9 KB

CORRESP

Sep 29, 2025

0001213900-25-093118

—

6.2 KB

UPLOAD

Sep 29, 2025

0000000000-25-010580

—

39.4 KB

F-1

Sep 22, 2025

0001213900-25-089916REGISTRATION STATEMENT

—

645.8 KB

6-K

Sep 22, 2025

0001213900-25-089839REPORT OF FOREIGN PRIVATE ISSUER

Sep 22, 2025

14.0 KB

6-K

Sep 11, 2025

0001213900-25-086668REPORT OF FOREIGN PRIVATE ISSUER

Sep 11, 2025

251.8 KB

EFFECT

Sep 8, 2025

9999999995-25-002864

—

1.9 KB

POS AM

Sep 4, 2025

0001213900-25-084488POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1

—

449.0 KB

6-K

Sep 2, 2025

0001213900-25-083373REPORT OF FOREIGN PRIVATE ISSUER

Jun 30, 2025

2.5 MB

6-K

Jun 12, 2025

0001213900-25-053720REPORT OF FOREIGN PRIVATE ISSUER

Jun 12, 2025

70.0 KB

424B3

Jun 5, 2025

0001213900-25-051480PROSPECTUS SUPPLEMENT

—

45.5 KB

6-K

Jun 5, 2025

0001213900-25-051478REPORT OF FOREIGN PRIVATE ISSUER

Jun 5, 2025

23.0 KB

6-K

Jun 2, 2025

0001213900-25-049688REPORT OF FOREIGN PRIVATE ISSUER

Jun 2, 2025

34.7 KB

EFFECT

May 15, 2025

9999999995-25-001620

—

1.9 KB

25 filings shown

Filed	Form	Description
11/14/24	SC 13G/A	SC 13G/A	→
8/20/24	SC 13G/A	AMENDMENT 3 TO SCHEDULE 13G	→
3/12/24	SC 13D	SCHEDULE 13D	→
2/14/24	SC 13G	SC 13G	→
1/24/24	SC 13G/A	AMENDMENT NO. 2 TO SCHEDULE 13G	→
1/2/24	SC 13G/A	SCNI 13GA 1.02.24	→
↓

Scinai Immunotherapeutics Ltd.

Financials

News (8-K)

Prospectuses & Registrations

Filing History(456 filings)

Ownership

Other Filings

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
10/1/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
9/30/25	EFFECT	EFFECT	→
9/8/25	EFFECT	EFFECT	→
9/4/25	POS AM	POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1	→
5/15/25	EFFECT	EFFECT	→
↓